Form 8-K - Current report:
SEC Accession No. 0001193125-25-321663
Filing Date
2025-12-17
Accepted
2025-12-17 07:00:13
Documents
14
Period of Report
2025-12-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d55858d8k.htm   iXBRL 8-K 25738
2 EX-99.1 d55858dex991.htm EX-99.1 89761
6 GRAPHIC g55858dsp004.jpg GRAPHIC 4142
  Complete submission text file 0001193125-25-321663.txt   250858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20251217.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20251217_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20251217_pre.xml EX-101.PRE 11254
17 EXTRACTED XBRL INSTANCE DOCUMENT d55858d8k_htm.xml XML 3656
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 251577220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)